Julian Baker’s Gyre Therapeutics GYRE Stock Holding History

Julian Baker’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-2,626	Closed	-$11M	–	96
2013 Q3	$11M	Buy	+2,626	New	+$10.6M	0.16%	41

Other funds holding GYRE

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Julian Baker's GYRE Position: Q4 2013 in Review

Julian Baker sold out of Gyre Therapeutics (GYRE) in Q4 2013, closing a stake of 2,626 shares — an estimated $11M sold.

Julian Baker first reported a position in GYRE in Q3 2013 and held it in 1 quarter. The position peaked at $11M in Q3 2013. 74 funds tracked by Wall St. Rank hold GYRE as of Q4 2013.

Julian Baker reported no remaining Gyre Therapeutics position as of Q4 2013 after selling out during the quarter.
Julian Baker sold 2,626 Gyre Therapeutics shares in Q4 2013, an estimated $11M.
Julian Baker first reported a position in Gyre Therapeutics in Q3 2013 and held it in 1 quarter.
Julian Baker's Gyre Therapeutics position peaked at $11M in Q3 2013.
74 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2013.

Based on Baker Bros. Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.